Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma

Cancer Research

Volumn 62, Issue 24, 2002, Pages 7154-7156

  Hoa, Michael ^a   Davis, Shannon L ^a   Ames, Sarah J ^a   Spanjaard, Remco A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; KERATINOCYTE; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR GROWTH; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; GENE AMPLIFICATION; GENES, RAS; HEAD AND NECK NEOPLASMS; HUMANS; TUMOR CELLS, CULTURED;

EID: 0037115610     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Williams, H. K. Molecular pathogenesis of oral squamous carcinoma. Mol. Pathol., 53: 165-172, 2000.
2. Ichikawa, T., Yano, Y., Uchida, M., Otani, S., Hagiwara, K., and Yano, T. The activation of K-ras gene at an early stage of lung tumorigenesis in mice. Cancer Lett, 107: 165-170, 1996.
3. Yamashita, N., Minamoto, T., Ochiai, A., Onda, M., and Esumi, H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology, 108: 434-440, 1995.
4. Yarbrough, W. G., Shores, C., Witsell, D. L., Weissler, M. C., Fidler, M. E., and Gilmer, T. M. Ras mutations and expression in head and neck squamous cell carcinomas. Laryngoscope, 104: 1337-1347, 1994.
5. Matsuda, H., Konishi, N., Hiasa, Y., Hayashi, I., Tsuzuki, T., Tao, M., Kitahori, Y., Yoshioka, N., Kirita, T., and Sugimura, M. Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions. J. Oral Pathol. Med., 25: 232-238, 1996.
6. Spencer, J. M., Kahn, S. M., Jiang, W., DeLeo, V. A., and Weinstein, I. B. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch. Dermatol., 131: 796-800, 1995.
7. McDonald, J. S., Jones, H., Pavelic, Z. P., Pavelic, L. J., Stambrook, P. J., and Gluckman, J. L. Immunohistochemical detection of the H-ras, K-ras and N-ras oncogenes in squamous cell carcinoma of the head and neck. J. Oral Pathol. Med., 23: 342-346, 1994.
8. Oft, M., Akhurst, R. J., Balmain, A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell. Biol., 4: 487-494, 2002.
9. Spanjaard, R. A., Ikeda, M., Lee, P. J., Charpentier, B., Chin, W. W., and Eberlein, T. J. Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARγ in induction of differentiation and apoptosis of S91 melanoma cells. J. Biol. Chem., 272: 18990-18999, 1997.
10. Giaccone, G. Oncogenes and antioncogenes in lung tumorigenesis. Chest, 109: 130S-134S, 1996.
11. Demary, K., Wong, L., and Spanjaard, R. A. Effects of retinoic acid and sodium butyrate on gene expression, histone acetylation and inhibition of proliferation of melanoma cells. Cancer Lett., 163: 103-107, 2001.
12. Su, Z-Z., Lebedeva, I. V., Gopalkrishnan, R. V., Goldstein, N. I., Stein, C. A., Reed, J. C., Dent, P., and Fisher, P. B. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc. Natl. Acad. Sci. USA, 98: 10332-10337, 2001.
13. Rodriguez-Puebla, M. L., LaCava, M., Bolontrade, M. F., Russell, J., and Conti, C. J. Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin. Mol. Carcinog., 26: 150-156, 1999.
14. Volpe, J. P., Conti, C. J., and Slaga, T. J. Characterization of mutant HA-ras gene expression in transformed murine keratinocyte lines grown under in vitro and in vivo conditions. Mol. Carcinog., 17: 202-206, 1996.
15. Chang, E. H., Furth, M. E., Scolnick, E. M., and Lowry, D. R. Tumorigenic transformation of mammalian cells induced by a normal human gene homologues to the oncogene of Harvey murine sarcoma virus. Nature (Lond.), 297: 479-482, 1982.
16. Rizos, E., Sourvinos, G., Arvanitis, D. A., Velegrakis, G., and Spandidos, D. A. Low incidence of H-, K- and N-ras oncogene mutations in cytologtical specimens of laryngeal tumours. Oral Oncol., 35: 561-563, 1999.
17. Chin, L., Tam, A., Pomerantz, J., Wong, M., Jocelyn, H., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., Horner, J. W., Cordon-Dardo, C., Yancopoulos, G. D., and DePinho, R. A. Essential role for oncogenic Ras in tumour maintenance. Nature (Lond.), 400: 468-472, 1999.